Pathfinder Pharma focuses on drug discovery research from invention through clinical proof of concept. They specialize in viral diseases and related cancers.
Company (Alive / Active)
North Carolina, United States
|Investor||Investor Type||Location||Participating Rounds|
|Burnaby, British Columbia, Canada||IPO / Went public||Xenon Pharmaceuticals is a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications that we intend to commercialize on our own, and for larger market indications that we intend to partner with global pharmaceutical industry leaders. The company has built a core platform, Extreme Genetics, enabling the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mut...Show all||Login to see details|
|Pittsburgh, Pennsylvania, United States||Acquired||Cellumen, Inc. is a Cellular Systems Biology Company. Cellumen focuses on the cell as an integrated and interacting network of genes, proteins and metabolites responsible for normal and abnormal (disease) function. To promote efficient drug discovery and development, the company aims to offer solutions to the dual challenges of efficacy and toxicity. The company's products and services have application in each of the major segments of the pharmaceutical pipeline: drug discovery ("cellular model...Show all||Login to see details|
|Title||Application Date||Patent Date||Status
(Patent / Application)